SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16,948.20 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 36,697.00 |
| Book Value / Share | 577.69 |
| Price / Book | n/a |
| NCAV ($M) | 18,740.00 |
| NCAV / Share | 295.01 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.21 |
| Return on Assets (ROA) | 0.22 |
| Return on Equity (ROE) | 0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.24 |
| Current Ratio | 5.25 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 27,854.00 |
| Assets | 45,811.00 |
| Liabilities | 9,114.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 21,526.00 |
| Operating Income | 7,003.00 |
| Net Income | 7,844.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 7,771.00 |
| Cash from Investing | -9,907.00 |
| Cash from Financing | -3,919.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
Financial data and stock pages provided by
Fintel.io